Mergers & Acquisitions - Pharmaceutical, Markets & Marketing


Popular Filters

Takeda acquires 13 products from Turkish company Neutec

Takeda acquires 13 products from Turkish company Neutec


Takeda GmbH, the wholly-owned subsidiary of Japanese drugmaker Takeda has signed an agreement to obtain…

Markets & MarketingMergers & AcquisitionsPharmaceuticalTakeda PharmaceuticalTurkey

Cipla enters joint venture in Morocco and eyes Serum Institute of India merger

Cipla enters joint venture in Morocco and eyes Serum Institute of India merger


Indian pharma company Cipla has announced that its UK subsidiary has entered into a joint venture agreement…

CiplaLicensingMarkets & MarketingMergers & AcquisitionsMoroccoPharmaceutical

Big pharma increasingly collaborating with Indian companies

Big pharma increasingly collaborating with Indian companies


Even as multinational pharma majors are looking for new ways to squeeze costs along the whole value chain,…

Gilead SciencesIndiaLicensingMarkets & MarketingMergers & AcquisitionsPharmaceuticalRussia

Global oncology market to hit $109 billion in 2020

Global oncology market to hit $109 billion in 2020


Cancer, with a death toll exceeding that of AIDS (acquired immune deficiency syndrome), tuberculosis…

AvastinCelgene Corp.GlobalMarkets & MarketingMergers & AcquisitionsNovartisOncologyPharmaceuticalResearchRevlimidRoche

GlaxoSmithKline takes stake in new Aspen Japanese unit

GlaxoSmithKline takes stake in new Aspen Japanese unit


South African drugmaker Aspen Pharmacare says that Aspen Global Inc, a subsidiary of Aspen Holdings,…

Aspen PharmacareGlaxoSmithKlineJapanMarkets & MarketingMergers & AcquisitionsPharmaceutical

Walgreens to buy remainder of Boots Alliance, but shuns inversion


US pharmacy giant Walgreen has exercised its option to buy the remaining 55% of European pharmacy retailer…

Alliance BootsEuropeMarkets & MarketingMergers & AcquisitionsPharmaceuticalWalgreens

Growing Indian pharma market provides incentives for foreign acquisitions


A recent IMS Institute for Healthcare Informatics global study has revealed that greater access to medicines…

Asia-PacificIndiaMarkets & MarketingMergers & AcquisitionsPharmaceutical

Report: M&A worth $11 billion in third quarter while Russian market shows promise

Report: M&A worth $11 billion in third quarter while Russian market shows promise


PricewaterhouseCoopers (PwC) has released its quarterly Life Sciences Deals Insights Quarterly for the…

BiotechnologyEuropeMarkets & MarketingMergers & AcquisitionsPharmaceutical

Alliance Boots and Walgreens expansion into China an "obvious next step," says EIU analyst


Following the news that Alliance Boots and the USA's Walgreen, which initially took a 45% stake in the…

Alliance BootsAsia-PacificMarkets & MarketingMergers & AcquisitionsPharmaceuticalWalgreens

Alliance Boots to build up interest in China


According to the Financial Times, Stefano Pessina, executive chairman of Alliance Boots, is looking to…

Alliance BootsAsia-PacificMarkets & MarketingMergers & AcquisitionsPharmaceuticalWalgreens

OPKO Health acquires 10% stake in Russia's Pharmsynthez


USA-based OPKO Health (NYSE: OPK) says it has acquired an approximate 10% stake in OAO Pharmsynthez (MICEX:…

EuropeLicensingMarkets & MarketingMergers & AcquisitionsOPKO HealthPharmaceuticalPharmsynthez

Analysis of China government incentives for pharma


China remains an attractive target for pharmaceutical research and manufacturing, and major players from…

Asia-PacificLicensingMarkets & MarketingMergers & AcquisitionsPatentsPharmaceutical

Aggressive strategies confirm Big Pharma's Indian interest


The increasing number of consolidations and in-licensing agreements between multinational corporations…

Asia-PacificLicensingMarkets & MarketingMergers & AcquisitionsPharmaceutical

Norgine and SpePharm set up JV to commercialize portfolio of drugs


Independent Dutch firm Norgine BV and fellow Amsterdam-based SpePharm Holding BV have concluded a broad…

Markets & MarketingMergers & AcquisitionsNorginePharmaceuticalSpePharma

India's Elder Pharma to enter EU markets; comment on GSK Indian OTC moves


Indian drugmaker Elder Pharmaceuticals says it is ready to enter the European Union market following…

Asia-PacificdiosminElder PharmaceuticalsEuropeGenericsGlaxoSmithKlineMarkets & MarketingMergers & AcquisitionsPharmaceuticalRegulation

Otsuka Pharma sets up joint venture in Turkey


Otsuka Pharmaceutical (TYO: 4768), a mid-size Japanese drugmaker, and Abdi ����¯�¿�½���¯���¿���½������¯������¿������½����¯�¿�½���¯���¿���½����¯�¿�½������°brahim…

Abdi IbrahimEuropeMarkets & MarketingMergers & AcquisitionsOtsukaPharmaceutical

Analyst insight: Sanofi eyes Columbia, Indonesia and Vietnam


Emerging markets, BRIC countries are words that have recently risen to prominence in a majority of pharmaceutical…

Asia-PacificLicensingMarkets & MarketingMergers & AcquisitionsPharmaceuticalSanofiSouth America

Japan's vulnerable pharma companies, by P Reed Maurer


Once upon a time Japan's pharma companies could be compared to a convoy of ships. The big and small,…

Asia-PacificLicensingManagementMarkets & MarketingMergers & AcquisitionsPharmaceutical

Pharmaceutical supply chain in Japan sees squeezed margins


Pressures felt in Japan as a result of the country's aging population, drug price revisions and patent…

Asia-PacificBiotechnologyFinancialMarkets & MarketingMergers & AcquisitionsPharmaceuticalPricing

Adcock Ingram expands in Indian pharma market buying Cosme Farma brands


South Africa's largest health care company Adcock Ingram (AIP: SJ) says it has reached an agreement to…

Adcock IngramCosme FarmaMarkets & MarketingMergers & AcquisitionsPharmaceutical

Sigma-Aldrich acquires Research Organics; opens new facility in China


USA-headquartered Sigma-Aldrich (Nasdaq: SIAL) has acquired all outstanding shares of Cleveland, Ohio-based,…

Asia-PacificGenericsMarkets & MarketingMergers & AcquisitionsNorth AmericaPharmaceuticalResearch OrganicsSigma-Aldrich

Back to top